Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Baird analyst Jeff Johnson maintains Alcon (NYSE:ALC) with a Outperform and raises the price target from $95 to $98.
Needham analyst David Saxon maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $101 to $98.
Metagenomi reports MGX-001 achieved functional FVIII activity in primates, supporting clinical plans for its hemophilia A gene ...
(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures...
US stock futures up, IHS and Alcon report positive earnings, Cisco and CAE also expected to do well, On Holding disappoints.
Alcon (NYSE:ALC) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.76 by 3.95 perc...
Mizuho analyst Anthony Petrone maintains Alcon (NYSE:ALC) with a Outperform and lowers the price target from $110 to $100.
30-Day Go-Shop Period to Actively Solicit Other Third-Party ProposalsNo Termination Fee Payable to Alcon if STAAR Terminates Me...
